TuisBHC • TSE
add
Bausch Health Companies Inc
Vorige sluiting
$6,82
Dagwisseling
$6,72 - $6,95
Jaarwisseling
$5,45 - $13,74
Markkapitalisasie
2,50 mjd CAD
Gemiddelde volume
442,53 k
P/V-verhouding
-
Dividend-opbrengs
-
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Mrt. 2025info | J/J-verandering |
---|---|---|
Inkomste | 2,26 mjd | 4,92% |
Bedryfskoste | 1,29 mjd | 6,18% |
Netto inkomste | -58,00 m | 9,38% |
Netto winsgrens | -2,57 | 13,47% |
Wins per aandeel | 0,61 | 2,86% |
EBITDA | 574,00 m | -7,27% |
Effektiewe belastingkoers | -82,98% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Mrt. 2025info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 1,13 mjd | 54,71% |
Totale bates | 26,42 mjd | -1,83% |
Totale aanspreeklikheid | 26,66 mjd | -1,57% |
Totale ekwiteit | -240,00 m | — |
Uitstaande aandele | 369,55 m | — |
Prys om te bespreek | -2,13 | — |
Opbrengs op bates | 2,54% | — |
Opbrengs op kapitaal | 3,14% | — |
Kontantvloei
Netto kontantverandering
(USD) | Mrt. 2025info | J/J-verandering |
---|---|---|
Netto inkomste | -58,00 m | 9,38% |
Kontant van bedrywe | 211,00 m | 0,00% |
Kontant van beleggings | -130,00 m | -78,08% |
Kontant van finansiering | -146,00 m | 57,06% |
Netto kontantverandering | -44,00 m | 78,74% |
Beskikbare kontantvloei | 149,88 m | -51,81% |
Meer oor
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in eye health, gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufacture and market branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.
On 13 July 2018, as Quebec, Canada-based Valeant Pharmaceuticals International, it changed its name to Bausch Health Companies. Wikipedia
HUB
Gestig
1959
Hoofkwartier
Webwerf
Werknemers
20 700